Session Learning Objectives:

1. Compare Left Atrial Appendage closure With Oral Anticoagulation In high Risk atrial fibrillation; What Have We Learned
2. Discuss Peridevice Leak After Left Atrial Appendage Closure: Impact On Long Term Thromboembolism and mortality

Session Faculty: Vivek Reddy, MD

Abbott (Consultant), Ablacon (Consultant, Equity), Acutus Medical (Consultant, Equity), Affera-Medtronic (Consultant, Equity), Apama Medical-Boston Scientific (Consultant, Equity), APN Health (Consultant, Equity), Aquaheart (Consultant, Equity), Atacor (Consultant, Equity), AtiAN (Consultant), Autonomix (Consultant, Equity), Axon Therapies (Consultant, Equity), Backbeat (Consultant, Equity), BioSig (Consultant, Equity), Biosense-Webster (Consultant), BioTel Heart (Consultant), Biotronik (Consultant), Boston Scientific (Consultant), Cairdac (Consultant), CardiaCare (Consultant, Equity), Cardiofocus (Consultant), Cardionomic (Consultant), CardioNXT / AFTx (Consultant, Equity), Circa Scientific (Consultant, Equity), CoreMap (Consultant), CoRISMA (Consultant, Equity), Corvia Medical (Consultant, Equity), Dinova-Hangzhou DiNovA EP Technology (Consultant, Equity), East End Medical (Consultant, Equity), EBR (Consultant), EPD-Philips (Consultant, Equity), EP Frontiers (Consultant, Equity), Epix Therapeutics (Consultant, Equity), EpiEP (Consultant, Equity), Eximo (Consultant, Equity), Farapulse-Boston Scientific (Consultant, Equity), Fire1 (Consultant), Focused Therapeutics (Consultant, Equity), Gore & Associates (Consultant), HRT (Consultant, Equity), Impulse Dynamics (Consultant), Intershunt (Consultant, Equity), Javelin (Consultant, Equity), Kardium (Consultant, Equity), Keystone Heart (Consultant, Equity), LuxMed (Consultant, Equity), Manual Surgical Sciences (Equity), Medlumics (Consultant, Equity), Medtronic (Consultant), Middlepeak (Consultant, Equity), Neutrace (Consultant, Equity), Newpace (Equity), Nuvera-Biosense Webster (Consultant, Equity), Oracle Health (Consultant, Equity), Philips (Consultant), Pulse Biosciences (Consultant), Restore Medical (Consultant, Equity), Sirona Medical (Consultant, Equity), Surecor (Equity), Valcare (Consultant, Equity) and Vizaramed (Equity).

Presenter plans  on discussing unlabeled/investigational uses of a commercial product and will disclose this to the audience. ablation catheters that are not yet approved